A Study to Investigate Apatinib Combined Capecitabine on Adjuvant Therapy of Biliary Carcinoma
Status:
Not yet recruiting
Trial end date:
2021-12-25
Target enrollment:
Participant gender:
Summary
It is a prospective,parallel study to investigate the saftety and efficacy of Apatinib
combined Capacitabine in the adjuvant treatment of the biliary cancinoma after operation.
Phase:
Phase 2
Details
Lead Sponsor:
First Affiliated Hospital of Guangxi Medical University